Post-mortem examination of Hospital Inpatient COVID-19 Deaths in Lusaka, Zambia - A Descriptive Whole-body Autopsy Series.
Africa
Autopsy
COVID-19
SARS-CoV-2
Zambia
hospital deaths
pathology
post-mortem
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
24
05
2021
revised:
04
06
2021
accepted:
07
06
2021
pubmed:
20
6
2021
medline:
20
8
2021
entrez:
19
6
2021
Statut:
ppublish
Résumé
Since information on the pathology of COVID-19 from sub-Saharan Africa (SSA) remains scarce, the objective of our study was to define the gross pathology and histological features of COVID-19. We report data from 29 whole-body autopsies of COVID-19 deaths occurring in hospitals in Lusaka, Zambia - the first large autopsy case series from Africa. We performed a descriptive post-mortem examination study of inpatient COVID-19 related deaths at two hospitals in Lusaka, Zambia. Whole-body autopsies were conducted according to Standard Operating Procedures. Gross and histopathological examinations of all organs were performed. Patient demographics, history, co-morbidities, autopsy gross and microscopic findings, and cause(s) of death were recorded and analyzed using STATA version 14. Variables were grouped and presented as frequencies and percentages. Autopsies were performed on 29 decedents (mean age = 44 ± 15.8years; age range = 19-82; 17/29 [58.8%] males). 22/29 [75.9%] cases were <55 years of age. A spectrum of pathological manifestations of COVID-19 were seen in all organs. The commonest causes of death were pulmonary thromboembolism (13/29, 45%), Diffuse Alveolar Damage (9/29, 31%), and COVID-19 pneumonia (7/29, 25%). 22/29 (76%) had co-morbidities. Common co-morbidities included HIV (8/29, 28%), Hypertension (6/29, 20%) Tuberculosis (3/29, 10%), Diabetes (3/29, 10%). A spectrum of gross anatomical and histopathological findings are seen in COVID-19 deaths in hospitalized decedents. These appear broadly similar to those reported from China, Europe and USA. Differences include a younger age group, and co-morbidities of HIV and TB co-infection which require further investigation.
Sections du résumé
BACKGROUND
BACKGROUND
Since information on the pathology of COVID-19 from sub-Saharan Africa (SSA) remains scarce, the objective of our study was to define the gross pathology and histological features of COVID-19. We report data from 29 whole-body autopsies of COVID-19 deaths occurring in hospitals in Lusaka, Zambia - the first large autopsy case series from Africa.
METHODS
METHODS
We performed a descriptive post-mortem examination study of inpatient COVID-19 related deaths at two hospitals in Lusaka, Zambia. Whole-body autopsies were conducted according to Standard Operating Procedures. Gross and histopathological examinations of all organs were performed. Patient demographics, history, co-morbidities, autopsy gross and microscopic findings, and cause(s) of death were recorded and analyzed using STATA version 14. Variables were grouped and presented as frequencies and percentages.
FINDINGS
RESULTS
Autopsies were performed on 29 decedents (mean age = 44 ± 15.8years; age range = 19-82; 17/29 [58.8%] males). 22/29 [75.9%] cases were <55 years of age. A spectrum of pathological manifestations of COVID-19 were seen in all organs. The commonest causes of death were pulmonary thromboembolism (13/29, 45%), Diffuse Alveolar Damage (9/29, 31%), and COVID-19 pneumonia (7/29, 25%). 22/29 (76%) had co-morbidities. Common co-morbidities included HIV (8/29, 28%), Hypertension (6/29, 20%) Tuberculosis (3/29, 10%), Diabetes (3/29, 10%).
CONCLUSIONS
CONCLUSIONS
A spectrum of gross anatomical and histopathological findings are seen in COVID-19 deaths in hospitalized decedents. These appear broadly similar to those reported from China, Europe and USA. Differences include a younger age group, and co-morbidities of HIV and TB co-infection which require further investigation.
Identifiants
pubmed: 34146690
pii: S1201-9712(21)00502-6
doi: 10.1016/j.ijid.2021.06.013
pmc: PMC8215884
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
363-369Subventions
Organisme : FIC NIH HHS
ID : D43 TW010354
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA221204
Pays : United States
Informations de copyright
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Références
Lancet Infect Dis. 2015 May;15(5):492-4
pubmed: 25765218
Afr J Lab Med. 2020 Jun 03;9(1):974
pubmed: 32537426
Prev Chronic Dis. 2020 Jul 16;17:E63
pubmed: 32678061
S Afr Med J. 2020 Oct 19;110(12):1195-1200
pubmed: 33403965
Diagn Pathol. 2020 Aug 14;15(1):103
pubmed: 32799894
Int J Infect Dis. 2021 Jan;102:118-122
pubmed: 33075535
J Infect Dis. 2020 Nov 9;222(11):1807-1815
pubmed: 32914853
Sci Rep. 2021 Mar 18;11(1):6283
pubmed: 33737527
Chest. 2020 Jul;158(1):43-44
pubmed: 32283063
Int J Legal Med. 2020 Jul;134(4):1275-1284
pubmed: 32500199
J Natl Med Assoc. 2021 Jun;113(3):324-335
pubmed: 33153755
Forensic Sci Med Pathol. 2021 Mar;17(1):101-113
pubmed: 33394313
BMJ Case Rep. 2021 Apr 21;14(4):
pubmed: 33883111
Lancet Infect Dis. 2020 Oct;20(10):1102-1103
pubmed: 32526191
PLoS One. 2020 Jun 23;15(6):e0234765
pubmed: 32574165
Int J Infect Dis. 2020 Dec;101:243-246
pubmed: 32987179
Forensic Sci Med Pathol. 2021 Jun;17(2):279-296
pubmed: 33026628
Mod Pathol. 2021 Aug;34(8):1456-1467
pubmed: 33795830
Natl Sci Rev. 2020 Sep;7(9):1414-1418
pubmed: 34192086
Front Immunol. 2020 Aug 28;11:2147
pubmed: 32983176